CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Exercise as an Adjuvant Therapy for Veterans with PTSDbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02295995
NCT02295995N/ACompleted
CompareCT.gov

Exercise as an Adjuvant Therapy for Veterans With PTSD

VA Office of Research and Development·interventional·Posted Nov 20, 2014·Updated Jan 29, 2020

In Brief

A clinical study evaluating Exercise as an Adjuvant Therapy for Veterans with PTSD for Post-traumatic. Completed, enrolled 54 participants across 1 site.

Detailed Summary

The purpose of this study is to examine whether posttraumatic stress disorder (PTSD) symptoms impact adherence to a 12-week physical activity program and whether exercise can help improve PTSD symptoms and health outcomes in older Veterans. Veterans over the age of 60 with PTSD were be recruited to participate in a 12-week physical activity program consisting of aerobic and strengthening activities. 54 participants were randomized to an intervention arm (n=36) or usual care wait-list control (n=18).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-traumatic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 20, 2014
Enrollment StartDec 18, 2015
Primary CompletionMay 8, 2018
Study CompletionApr 15, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 11.6 years ago

Interventions

Exercise as an Adjuvant Therapy for Veterans with PTSDbehavioral

Methods: Approximately 50 Veterans 60 years and older with PTSD will be recruited to participate in a 12-week physical activity program consisting of aerobic and strength-training activities. Participants will be randomized to an intervention arm or usual care wait-list control. Outcomes: Changes in physical function, PTSD symptom severity, and aerobic endurance will be assessed between the two study arms. Secondary outcomes include compliance with the intervention, pain, sleep, and psychological well-being.